𝔖 Bobbio Scriptorium
✦   LIBER   ✦

MRI Monitoring of Tumor Response to a Novel VEGF Tyrosine Kinase Inhibitor in an Experimental Breast Cancer Model

✍ Scribed by Roberts, Timothy P.L; Wood, Jeanette M; Fu, Yanjun; Carter, Wayne O; Brasch, Robert C; Turetschek, Karl; Preda, Anda; Floyd, Eugenia; Shames, David M; Novikov, Viktor

Book ID
122762994
Publisher
Elsevier Science
Year
2002
Tongue
English
Weight
31 KB
Volume
9
Category
Article
ISSN
1076-6332

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

MRI methods for evaluating the effects o
MRI methods for evaluating the effects of tyrosine kinase inhibitor administration used to enhance chemotherapy efficiency in a breast tumor xenograft model
✍ S.O. Aliu; L.J. Wilmes; M.M. Moasser; B.C. Hann; K.-L. Li; D. Wang; N.M. Hylton πŸ“‚ Article πŸ“… 2009 πŸ› John Wiley and Sons 🌐 English βš– 472 KB πŸ‘ 2 views

## Abstract ## Purpose To evaluate whether quantitative MRI parameters are sensitive to the effects of the tyrosine kinase inhibitor gefitinib and can discriminate between two different treatment protocols. ## Materials and Methods Untreated mice with BT474 breast tumor xenografts were character

Heterogeneity in the angiogenic response
Heterogeneity in the angiogenic response of a BT474 human breast cancer to a novel vascular endothelial growth factor-receptor tyrosine kinase inhibitor: Assessment by voxel analysis of dynamic contrast-enhanced MRI
✍ Ka-Loh Li; Lisa J. Wilmes; Roland G. Henry; Maria G. Pallavicini; John W. Park; πŸ“‚ Article πŸ“… 2005 πŸ› John Wiley and Sons 🌐 English βš– 783 KB

## Abstract ## Purpose To investigate the heterogeneity in the angiogenic response of a human breast cancer xenograft to a novel vascular endothelial growth factor (VEGF)‐receptor tyrosine kinase inhibitor, AG‐013736, using dynamic contrast‐enhanced MR imaging (DCE‐MRI). ## Materials and Methods